← Back to Search

Behavioral Intervention

Peer Support for Type 2 Diabetes (OASIS Trial)

N/A
Recruiting
Research Sponsored by University of Kentucky
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up collected at baseline, 3 month, and 6 month follow up.
Awards & highlights
No Placebo-Only Group

Summary

This trial aims to study if peer coaching can help older adults with unmanaged type two diabetes better manage their condition. They will train peer coaches to reach out to participants regularly to discuss self-management and goals

Who is the study for?
This trial is for older adults with unmanaged type two diabetes living in Appalachia. Participants should be interested in peer coaching to help manage their condition. They must not have any conditions that would interfere with the study or make it unsafe for them.
What is being tested?
The OASIS trial is testing whether peer coaching can help people better manage type two diabetes. It involves trained coaches reaching out regularly to discuss self-management and goal setting, while keeping records of these interactions.
What are the potential side effects?
Since this trial focuses on peer support rather than medication, there are no direct medical side effects expected from participating. However, participants may experience emotional or psychological impacts from regular discussions about their health.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~collected at baseline, 3 month, and 6 month follow up.
This trial's timeline: 3 weeks for screening, Varies for treatment, and collected at baseline, 3 month, and 6 month follow up. for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Number of participants with change in A1c
Secondary study objectives
Acts of Daily Living
Depression Scale
Diabetes Empowerment
+5 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

4Treatment groups
Experimental Treatment
Group I: Peer Participant Group DExperimental Treatment1 Intervention
Participants will be matched with a peer coach and will receive contact every 2 weeks.
Group II: Peer Participant Group CExperimental Treatment1 Intervention
Participants will be matched with a peer coach and will receive contact once a week
Group III: Peer Participant Group BExperimental Treatment1 Intervention
Participants will self-selected their peer coach and will receive contact every 2 weeks
Group IV: Peer Participant Group AExperimental Treatment1 Intervention
Participants will self-select their peer coach and will receive contact once a week.

Find a Location

Who is running the clinical trial?

Department of Health and Human ServicesFED
231 Previous Clinical Trials
935,473 Total Patients Enrolled
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)NIH
2,443 Previous Clinical Trials
4,331,068 Total Patients Enrolled
University of KentuckyLead Sponsor
191 Previous Clinical Trials
223,446 Total Patients Enrolled
~45 spots leftby Dec 2025